Pulnovo Medical announced today that it received two FDA investigational device exemption (IDE) approvals for its technology. Shanghai-based Pulnovo won IDEs for its pulmonary artery denervation (PADN) catheter and generator. It can now evaluate its technology in studies for Group I and Group II pulmonary hypertension (PH) patients. With full CMS … [Read more...] about Pulnovo earns duo of FDA IDE nods for hypertension treatment
Pulnovo Medical
Pulnovo enrolls first patients in artery denervation trial
Pulnovo Medical announced today that it enrolled the first two patients in a clinical study evaluating its pulmonary artery denervation (PADN) treatment. The company's PADN treatment utilizes a multi-pole pulmonary artery radiofrequency (RF) ablation catheter and RF ablation generator. It aims to treat pulmonary hypertension associated with left … [Read more...] about Pulnovo enrolls first patients in artery denervation trial
